title: [Protracted recurrent neuroleptic malignant syndrome].
abstract: The natural course of untreated neuroleptic malignant syndrome (NMS) does not usually exceed 3 weeks. Its duration is reduced by dantrolene and/or bromocriptine. We report a patient in whom NMS developed after an injection of haloperidol decanoate and fluctuated during 3 months. This was due perhaps because the initial treatment with oral neuroleptic was pursued, or because the doses of dantrolene were insufficient.
authors.affiliation: Service de Clinique Neurologique, CHU, Lille.
authors.forename: O
authors.initials: O
authors.lastname: Delerue
authors.forename: A
authors.initials: A
authors.lastname: Destée
mesh_terms: D000328:Adult; D001971:Bromocriptine / Q000627:therapeutic use; D003620:Dantrolene / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy / Q000503:physiopathology*; D012008:Recurrence
chemical_list: D001971:Bromocriptine; D003620:Dantrolene; D006220:Haloperidol
vernacular_title: Syndrome malin des neuroleptiques prolongé et à rechutes.